SI
SI
discoversearch

Biotech / Medical : Immunomedics (IMMU) - moderated
IMMU 25.400.0%Jul 17 8:00 PM EDTNews

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Fitzhughlaw12/30/2017 4:05:21 PM
18 Recommendations

Recommended By
btlbail1
captcobra1
CelebrityEquity
corndog
erippetoe

and 13 more members

   of 46857
 
I will demur on responding to the implications of my [ahem] future lifestyle other than to say that unlike prior years, I am cautiously optimistic that I will not be using my car as my mailing address and considering it to be an "island residence" because it's up on blocks out in some remote swamp - but I digress. Recalling the debate on whether we should have voted for the Gold or White slate, I thought it might be interesting to review our year operating under the "In 'Zad We Trust" construct.

There are certainly more events that could be included here, but this is my snapshot of key milestones for what I think we can all regard as an amazing, and unexpectedly successful, 2017:

Date

Open

High

Low

Close

Adj Close

Volume

December 30, 2016

3.64

3.68

3.56

3.67

3.67

672,600

March 9, 2017*

5.04

6.08

4.79

6.01

6.01

17,513,600

May 5, 2017**

6.31

6.92

6.03

6.36

6.36

24,557,300

August 24, 2017***

9.75

10.68

9.75

10.68

10.68

7,801,100

November 10, 2017****

11.50

12.83

11.41

12.40

12.40

8,081,900

December 4, 2017*****

10.50

10.72

8.80

9.00

9.00

5,867,000

December 7, 2017******

10.26

12.11

10.26

11.86

11.86

8.598,200

December 29, 2017*******

16.43

17.05

16.00

16.16

16.16

4,163,864

* Vice Chancellor Laster Issues Injunction Halting SGEN Deal; Interim BOD Seated With Gold Slate Majority

** PPS has 19% Gain Over Prior Day’s Close of $5.41 With Announcement of Private Placement Financing, Departure of Goldenberg and Sullivan, and Seattle Genetics and IMMU Joint Announcement of Termination of the Licensing Agreement. In the Next Trading Session, PPS Gains Another 8% (Closes at $6.86).

*** Company Confirms BLA Filing in Q1 2018 During Fiscal Q4 Earnings Call [PPS Had Closed at $7.78 on August 16th]

**** Michael Pehl Named CEO on November 9th

***** First Trading Day After Cramer Sell Recommendation of December 1

****** First Trading Day After December 6th SABCS Data Release and Investor Presentation

******* PPS gain of 440% for the year

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

Copyright © 1995-2018 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.